Evidence map›Paper›PMID 26077564›Full record

ArticleHypertension (Dallas, Tex. : 1979)2015

Angiotensins and the heart: is angiotensin-(1-7) cardioprotective?

Jan Wysocki, Lisa Wilsbacher, Daniel Batlle

Abstract readEditorialComment
In one paragraph

Article in Hypertension (Dallas, Tex. : 1979), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Review
  2. Angiotensin 1-7 in an experimental septic shock model.Critical care (London, England) · 2023
    Article
  3. [Angiotensin Ⅱ inhibits AMPK/SIRT1 pathway by inducing oxidative stress in RAW264.7 macrophages].Nan fang yi ke da xue xue bao = Journal of Southern Medical University · 2021
    Article
  4. Article
  5. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Jan WysockiFrom the Division of Nephrology and Hypertension (J.W., D.B.) and Division of Cardiology and Feinberg Cardiovascular Research Institute (L.W.), Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.
Lisa WilsbacherFrom the Division of Nephrology and Hypertension (J.W., D.B.) and Division of Cardiology and Feinberg Cardiovascular Research Institute (L.W.), Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL.
Daniel BatlleFrom the Division of Nephrology and Hypertension (J.W., D.B.) and Division of Cardiology and Feinberg Cardiovascular Research Institute (L.W.), Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. d-batlle@northwestern.edu.

Funding

Strategies for ACE2 Amplification to Treat Diabetic Kidney DiseaseR01DK080089 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI BATLLE, DANIEL · 2009 to 2012
$1.3M
NIDDK NIH HHS 1R01DK080089-01A2NIDDK NIH HHS R01 DK080089
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiotensin IAnimalsBlood PressureDesoxycorticosterone AcetateHeart Failure, DiastolicMalePeptide FragmentsAngiotensin IDesoxycorticosterone AcetatePeptide Fragments

Identifiers

PMID26077564
PMCPMC4624410

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.